17June2017. Parampal Deol, Ph.D, MBA Senior Director, R&D Microbiology North America

Similar documents
Guidelines for Laboratory Verification of Performance of the FilmArray BCID System

SYMMETRY FOAMING HAND SANITIZER with Aloe & Vitamin E Technical Data

2 0 hr. 2 hr. 4 hr. 8 hr. 10 hr. 12 hr.14 hr. 16 hr. 18 hr. 20 hr. 22 hr. 24 hr. (time)

CultiControl. Technical Sheet 01

TEST REPORT. Client: M/s Ion Silver AB. Loddekopinge. Sverige / SWEDEN. Chandran. min and 30 min. 2. E. coli. 1. S. aureus

C&W Three-Year Cumulative Antibiogram January 2013 December 2015

4 th and 5 th generation cephalosporins. Naderi HR Associate professor of Infectious Diseases

microbiology testing services

Liofilchem Chromatic Chromogenic culture media for microbial identification and for the screening of antimicrobial resistance mechanisms

Cleaning and Disinfection Protocol Vegetative Bacteria

BACTERIAL SUSCEPTIBILITY REPORT: 2016 (January 2016 December 2016)

Test Method Modified Association of Analytical Communities Test Method Modified Germicidal Spray Products as Disinfectants

ANTIMICROBIAL TESTING. with ALKA VITA (ALKAHYDROXY ) ESCHERICHIA COLI STAPHYLOCOCCUS AUREUS (MRSA) PSEUDOMONA AERUGINOSA ENTEROBACTER CLOACAE

Cleaning and Disinfection Protocol for Gram-Negative and Gram-Positive Bacteria, including Antibiotic Resistant Bacteria

Concise Antibiogram Toolkit Background

Vitek QC Sets. Vitek 2 Identification QC Sets

Comparison of BD BACTEC Plus Blood Culture Media versus VersaTREK REDOX

SUMMARY OF TESTS BEING EXECUTED WITH OXILITE OR NEUTRAL OXILITE PRODUCED ON WPT WATER-MASTER EQUIPMENT.

Finnzymes Oy. PathoProof Mastitis PCR Assay. Real time PCR based mastitis testing in milk monitoring programs

3 Infection Prevention Solutions

TECHNICAL BULLETIN PURELL Advanced with Aloe Instant Hand Sanitizer

EXTENDED-SPECTRUM BETA-LACTAMASE (ESBL) TESTING

In Vitro Antimicrobial Activity of CP-99,219, a Novel Azabicyclo-Naphthyridone

CONTAGIOUS COMMENTS Department of Epidemiology

QUICK REFERENCE. Pseudomonas aeruginosa. (Pseudomonas sp. Xantomonas maltophilia, Acinetobacter sp. & Flavomonas sp.)

GeNei TM. Antibiotic Sensitivity. Teaching Kit Manual KT Revision No.: Bangalore Genei, 2007 Bangalore Genei, 2007

PDF hosted at the Radboud Repository of the Radboud University Nijmegen

RCH antibiotic susceptibility data

2012 ANTIBIOGRAM. Central Zone Former DTHR Sites. Department of Pathology and Laboratory Medicine

Aberdeen Hospital. Antibiotic Susceptibility Patterns For Commonly Isolated Organisms For 2015

The Disinfecting Effect of Electrolyzed Water Produced by GEN-X-3. Laboratory of Diagnostic Medicine, College of Medicine, Soonchunhyang University

Study Type of PCR Primers Identified microorganisms

SYMMETRY ANTIMICROBIAL FOAMING HANDWASH with 0.3% PCMX Technical Data

INFECTIOUS DISEASES DIAGNOSTIC LABORATORY NEWSLETTER

MASTITIS DNA SCREENING

In Vitro Activity of Netilmicin, Gentamicin, and Amikacin

2017 Antibiogram. Central Zone. Alberta Health Services. including. Red Deer Regional Hospital. St. Mary s Hospital, Camrose

MICROBIOLOGY of RAW MILK

Pathogens commonly isolated from selected diseases

< x 10 6 > % > 5.8

2015 Antibiogram. Red Deer Regional Hospital. Central Zone. Alberta Health Services

Disk Susceptibility Studies with Cefazolin and Cephalothin

Lab Exercise: Antibiotics- Evaluation using Kirby Bauer method.

Leveraging the Lab and Microbiology Department to Optimize Stewardship

OYRON WELL D-ONE Rev /10/2015

MICRONAUT MICRONAUT-S Detection of Resistance Mechanisms. Innovation with Integrity BMD MIC

Mastitis: Background, Management and Control

2016 Antibiogram. Central Zone. Alberta Health Services. including. Red Deer Regional Hospital. St. Mary s Hospital, Camrose

Antimicrobial Stewardship Strategy: Antibiograms

Objectives. Basic Microbiology. Patient related. Environment related. Organism related 10/12/2017

Help with moving disc diffusion methods from BSAC to EUCAST. Media BSAC EUCAST

Supplementary Appendix

Appropriate antimicrobial therapy in HAP: What does this mean?

Media Issued by: LABORATORY MANAGER Original Date: April 11, 2001 Approved by: Laboratory Director Revision Date: February 27, 2004

Table 1. Commonly encountered or important organisms and their usual antimicrobial susceptibilities.

CUMULATIVE ANTIBIOGRAM

Principles of Infectious Disease. Dr. Ezra Levy CSUHS PA Program

6.0 ANTIBACTERIAL ACTIVITY OF CAROTENOID FROM HALOMONAS SPECIES AGAINST CHOSEN HUMAN BACTERIAL PATHOGENS

Safety and Accuracy Assessment of MALDI-TOF Mass Spectrometry Platforms for the Detection of Biological Threats

BactiReg3 Event Notes Module Page(s) 4-9 (TUL) Page 1 of 21

MARBOCYL FD SUMMARY OF PRODUCT CHARACTERISTICS

Isolation of Urinary Tract Pathogens and Study of their Drug Susceptibility Patterns

New Opportunities for Microbiology Labs to Add Value to Antimicrobial Stewardship Programs

Evaluation of the AutoMicrobic System for Susceptibility Testing of Aminoglycosides and Gram-Negative Bacilli

Determination of antibiotic sensitivities by the

Dairy/Milk Testing Report Detecting Elevated Levels of Bacteria in Milk-On-Site Direct- From-The-Cow Within Minutes as Indicator of Mastitis

Mastitis and On-Farm Milk Cultures - A Field Study - Part 1

CONTAGIOUS COMMENTS Department of Epidemiology

Evaluation of a computerized antimicrobial susceptibility system with bacteria isolated from animals

Microbial landscape of surgical hospital. Biology and Medicine

Infection Linelist. Infections Occurred Between 10/1/ :00:00 AM To 11/1/ :00:00 AM 2RCW2. Gastroenteritis (Adult) Urinary Tract

Recommendations Regarding Use of Rapid Blood Pathogen Identification Panel Data

Quality assurance of antimicrobial susceptibility testing

Cleaning & Sanitising Medical range. Working in harmony with nature to protect

Reassessment of the "Class" Concept of Disk Susceptibility Testing

No-leaching. No-resistance. No-toxicity. >99.999% Introducing BIOGUARD. Best-in-class dressings for your infection control program

Mercy Medical Center Des Moines, Iowa Department of Pathology. Microbiology Department Antibiotic Susceptibility January December 2016

Interpretation of Bulk Tank Milk Results

Standing Orders for the Treatment of Outpatient Peritonitis

Staldren for all animals

THE MOLECULAR GENETIC ANALYSIS OF

ESCMID Online Lecture Library. by author

THE NAC CHALLENGE PANEL OF ISOLATES FOR VERIFICATION OF ANTIBIOTIC SUSCEPTIBILITY TESTING METHODS

Do clinical microbiology laboratory data distort the picture of antibiotic resistance in humans and domestic animals?

Using SCC to Evaluate Subclinical Mastitis Cows

Susceptibility Testing and Resistance Phenotypes Detection in Bacterial Pathogens Using the VITEK 2 System

New and Innovative Applications for Metals COPPER. Tony Lea International Copper Association

GENTAMICIN SULFATE- gentamicin sulfate solution/ drops Pacific Pharma, Inc GENTAMICIN SULFATE ophthalmic s olution, USP 0.

IV Antibiotics for Lyme Disease (Ceftriaxone, Cefotaxime sodium, Doxycycline, Penicillin G potassium)

1/30/ Division of Disease Control and Health Protection. Division of Disease Control and Health Protection

Taking Action to Prevent and Manage Multidrug-resistant Organisms and C. difficile in the Nursing Home: Part 1 Reviewing the organisms

INFECTION PREVENTION SILVER ANTI-MICROBIAL TEXTILES

CAVICIDE1. Technical Bulletin

Q1. (a) Clostridium difficile is a bacterium that is present in the gut of up to 3% of healthy adults and 66% of healthy infants.

Cost high. acceptable. worst. best. acceptable. Cost low

Antibiotic. Antibiotic Classes, Spectrum of Activity & Antibiotic Reporting

Antimicrobial Copper Touch Surfaces: A new tool for Infection Control and Prevention

2015 Antibiotic Susceptibility Report

HPN HOSPITALIZED PNEUMONIA APPLICATION

Quality Milk. got milk? Milk Quality. Why Bacteria in Milk Matters. Bacteria in Milk. Milk.One of Mother Nature s Most Perfect Foods

Transcription:

RAPID DETECTION OF BACTERIAL CONTAMINANTS IN PLATELET COMPONENTS: COMPARISON OF TIME TO DETECTION BETWEEN THE BACT/ALERT 3D AND THE BACT/ALERT VIRTUO SYSTEMS. 17June2017 Parampal Deol, Ph.D, MBA Senior Director, R&D Microbiology North America

The new generation of BacT/ALERT for Platelet Bacterial Screening 2

Higher throughput, full automation, faster time to detection Fully automated growth detection system Set & forget Place bottles on conveyor & walk away Automatic loading & unloading of bottles from the racks 3 times faster bottle loading Better thermal stability No drawers to open when loading and unloading Potential for reduced false positives Modular and scalable 2/3 the floor space vs. BacT/ALERT 3D Increase testing capacity and optimize lab space No change in consumables, inoculation or incubation protocols 3

Optimized footprint -30% 240 240 240 240 240 432 432 432 3m 2.17m BacT/ALERT 3D 1200 (5 x 240 configuration) BacT/ALERT VIRTUO 1296 (3 x 432 configuration) 4

Improved hardware & software Improved robustness Improved optics Improved sensitivity Improved specificity Faster time to detection (TTD) ~15% shorter TTD* Increased patient safety Potential to minimize false positive Minimized temperature fluctuations Increased efficiency * Shown in clinical trials 5

Purpose and Study Design Goal: Validate the performance of VIRTUO for use with BPA and BPN bottles with pooled platelet preparations For optimal recovery and sensitivity use of paired Aerobic (BPA) and Anaerobic (BPN) bottles are recommended. Study Design: Growth Performance Comparison testing: Two sites - NHS Blood and Transplant, London - biomerieux (bmx), Durham, USA Leukocyte Reduced platelet concentrate: Buffy coats and LRAP - NHS Sites: Buffy coats - Whole Blood Derived with plasma only - Whole Blood Derived plasma + Platelet additive solution (SSP+-Safe Platelets through saved plasma-macopharma) - bmx site: LRAP (American Red Cross) - LRAP from single donor without PAS were pooled from 4-6 donors 6

Study Design Testing Overview Most prevalent contaminants were selected - Aliquots of pooled platelet preparations were seeded with low levels (<1-31 CFU/ml) of organism with BioBall TM or ATCC - NHS: 11 species of organisms tested - bmx: 13 species of organisms tested Volume and Bottles - NHS: 8 ml volume per bottle was used for buffy coat testing (800 bottles) - bmx: 4 ml volume per bottle was used for LRAP testing (192 bottles) - False positives: 144 additional bottles were tested with 10 ml of LRAP BPA and BPN Bottles were loaded onto the VIRTUO and BTA 3D 7

Organisms tested by NHS Microorganisms ATCC/NCTC (bioball TM ) Strain Staphylococcus aureus NCTC 10788 Staphylococcus epidermidis NCTC 6513 Enterobacter cloacae ATCC 29005 Escherichia coli NCTC 12241 Klebsiella pneumoniae ATCC 8045 Bacillus cereus NCTC 7464 Salmonella choleraesuis ATCC 8326 Streptococcus agalactiae ATCC 12927 Pseudomonas aeruginosa (BPA only) NCTC 12924 Serratia marcescens ATCC 43862 Clostridium perfringens (BPN only) NCTC 8798 8

Organisms Tested by bmx Site Microorganism ATCC/NCTC (bioball TM ) Strain Bacillus cereus NCTC 7464 Enterobacter cloacae ATCC 33549 Esherichia coli NCTC 12241 Klebsiella pneumoniae ATCC 35657 Pseudomonas aeruginosa (BPA only) NCTC 12924 Proteus mirabilis ATCC 7002 Salmonella enterica NCTC 12023 Salmonella choleraesuis ATCC 10729 Serratia marcescens ATCC 43862 Staphylococcus aureus NCTC 10788 Staphylococcus epidermidis NCTC 6513 Streptococcus sanguinis ATCC 10556 Clostridium perfringens (BPN only) NCTC 8798 9

Results Summary of Results: NHS site with buffy coat - Both systems (VIRTUO and 3D) detected 800/800 (100%) of bottles seeded with organism regardless of platelet preparation type - VIRTUO average time to detection 2.1 hours faster than BTA 3D biomerieux, Durham, USA with LRAP - VIRTUO detected 144/144 (100%) of bottles seeded with organism - BTA 3D detected 48/48 (100%) of bottles seeded with organism - VIRTUO average time to detection 2.8 hours faster than BTA 3D Negative Controls - No false positives in LRAP testing (0%) - 1/800 BacT/ALERT BPN on BTA 3D was declared positive with buffy coat (0.13%). Data from these studies were presented as a poster at 34 th ISBT, Dubai - Poster # 589/ P-300, DOI: 10.13140/RG.2.2.23879.50084 10

Results with Buffy Coat in Plasma Number of positive cultures Time to detection (hours) Microorganism Bacillus cereus NCTC7464 Bottle type Inoculum (CFU/mL) BTA 3D BTA VIRTUO n=10 n=10 mean range mean range BPA 4 10 10 10.1 9.9-10.3 8.1 7.9-8.3 BPN 2 10 10 10.7 10.1-11.6 8.5 7.9-9.0 Clostridium perfringens NCTC8798 BPN 2 10 10 11.4 10.4-13.9 8.9 8.0-10.6 Enterobacter cloacae BPA 23 10 10 14.8 14.4-15.2 12.6 12.2-13.3 ATCC29005 BPN 23 10 10 11.4 11.2-11.4 8.9 8.6-9.1 Escherichia coli NCTC12241 Klebsiella pneumoniae ATCC8045 BTA 3D BTA VIRTUO BPA 4 10 10 12.7 12.4-13.1 10.3 10.1-10.5 BPN 3 10 10 11.6 11.4-11.7 9.9 9.5-10.1 BPA 10 10 10 15.3 15.0-16.2 13.7 12.9-15.2 BPN 8 10 10 12.9 12.5-13.0 11.1 10.9-11.4 Pseudomonas aeruginosa ATCC27853 BPA 14 10 10 16.7 16.3-16.9 13.8 13.6-14.0 Salmonella choleraesuis ATCC8326 Serratia liquefaciens ATCC35551 Staphylococcus aureus NCTC10788 Staphylococcus epidermidis NCTC6513 BPA 14 10 10 15.6 14.9-16.1 12.6 12.3-13.4 BPN 13 10 10 10.9 10.8-11.3 8.7 8.6-8.9 BPA 1 10 10 16.1 16.0-16.3 14 13.6-14.4 BPN 2 10 10 14.6 14.3-15.2 13.4 12.5-14.3 BPA 2 10 10 18 17.7-18.4 15.2 15.0-16.0 BPN 4 10 10 15.7 15.0-16.5 13.9 12.9-14.6 BPA 3 10 10 17.5 17.2-17.7 15.3 15.0-15.5 BPN 3 10 10 18.9 16.4-20.9 16.1 15.0-17.8 Streptococcus agalactiae BPA 20 10 10 10.9 10.7-11.1 8.3 8.0-8.5 ATCC 12927 BPN 21 10 10 10.2 10.1-10.4 7.9 7.8-8.2 Positive 200 200 13.8 11.6 Total % Recovery 100% 100% All bottles were positive Virtuo was on average 2.2 hours faster than BTA 3D 11

Results with Buffy Coat in Plasma with SSP+(PAS) Number of positive cultures Time to detection (hours) Microorganism Bacillus cereus NCTC7464 Bottle type Inoculum (CFU/mL) BTA 3D BTA VIRTUO n=10 n=10 mean range mean range BPA 3 10 10 9.8 9.5-10.0 8 7.8-8.0 BPN 2 10 10 11.7 10.7-12.7 9.9 8.6-10.9 Clostridium perfringens NCTC8798 BPN 3 10 10 10.3 9.7-11.2 8.4 8.3-8.8 Enterobacter cloacae BPA 21 10 10 12.3 12.2-12.6 9.8 9.7-9.9 ATCC29005 BPN 16 10 10 11.4 11.2-11.6 9 8.8-9.2 Escherichia coli NCTC12241 Klebsiella pneumoniae ATCC8045 BPA 2 10 10 12.1 11.9-12.3 10.2 9.9-10.6 BPN 3 10 10 11.1 10.9-11.3 9.6 9.3-9.8 BPA 9 10 10 13.5 13.5-13.7 11.6 11.3-11.8 BPN 9 10 10 13 12.7-13.2 11.1 10.8-11.4 Pseudomonas aeruginosa ATCC27853 BPA 18 10 10 16 15.7-16.2 13.7 13.2-14.4 Salmonella choleraesuis BPA 24 10 10 12 11.7-12.2 9.8 9.6-10.1 ATCC8326 BPN 19 10 10 10.9 10.7-11.0 9 8.7-9.2 Serratia liquefaciens ATCC35551 Staphylococcus aureus NCTC10788 Staphylococcus epidermidis NCTC6513 BPA 1 10 10 16.3 16.1-16.6 14.2 13.8-14.7 BPN 2 10 10 16.8 16.0-17.3 15.1 14.5-15.5 BPA 4 10 10 17.3 17.1-17.4 14.8 14.5-15.5 BPN 3 10 10 16.2 15.6-16.7 14.2 13.6-15.1 BPA 4 10 10 17.9 17.6-18.1 16 15.7-16.5 BPN 3 10 10 18.9 17.8-19.8 18.8 14.7-19.7 Streptococcus agalactiae BPA 19 10 10 10.4 10.3-10.4 8.6 8.5-8.7 ATCC12927 BPN 19 10 10 10.2 9.9-10.4 8.3 8.1-8.6 Positive 200 200 13.4 11.5 Total % Recovery 100% 100% All bottles were positive Virtuo was on average 1.9 hours faster than BTA 3D BTA 3D BTA VIRTUO 12

Results Testing with LRAP Number of positive cultures Time to detection (hours) Bottle Type Inoculum CFU/ml BTA VIRTUO Microorganism BTA 3D BTA 3D BTA VIRTUO n=2 n=6 mean range mean range BPA 2 6 10.4 10.3-10.6 7.5 7.2-7.9 Bacillus cereus NCTC7464 1 BPN 2 6 13.8 13.7-13.9 11.5 9.5-12.7 Clostridium perfringens NCTC8798 BPN 1 2 6 10.2 10.1-10.3 7.5 7.0-7.8 Escherichia coli NCTC12241 BPA 2 6 13 12.7-13.2 9.8 9.7-10.0 1 BPN 2 6 11.6 11.5-11.8 9 8.9-9.2 Pseudomonas aeruginosa NCTC12924 BPA 1 2 6 17 16.6-17.5 13.8 13.2-14.6 Salmonella typhimurium BPA 2 6 13.9 13.9* 10.8 10.5-11.3 1 NCTC12023 BPN 2 6 12.1 12.0-12.2 9.6 9.0-10.1 Staphylococcus aureus NCTC10788 Staphylococcus epidermidis NCTC6513 Enterobacter cloacae ATCC33549 Klebsiella pneumoniae ATCC35657 BPA 2 6 16.8 16.6-17.0 14.1 13.3-15.1 1 BPN 2 6 18.1 17.8-18.5 14.3 13.9-14.9 BPA 2 6 18.7 18.5-19.0 14.9 14.2-15.3 1 BPN 2 6 22.2 21.8-22.6 18 17.4-18.7 BPA 2 6 22.7 22.1-23.3 22.5 18.3-26.6 1 BPN 2 6 13.2 13.2* 10 9.8-10.1 BPA 2 6 12 12.0* 9.4 9.1-9.7 1 BPN 2 6 12.1 12.0-12.2 9.6 9.4-9.7 BPA 2 6 13.1 13.0-13.2 10.8 10.3-11.4 Proteus mirabilis ATCC7002 3 BPN 2 6 11.6 11.5-11.8 9.2 8.9-9.6 Salmonella choleraesuis ATCC10729 Serratia marcescens ATCC43862 BPA 2 6 12.8 12.7-13.0 10.1 9.9-10.3 4 BPN 2 6 11.6 11.5-11.8 9.3 9.1-9.4 BPA 2 6 12.1 12.0-12.2 9.7 9.6-9.9 3 BPN 2 6 12.5 12.5* 10.1 9.8-10.3 Streptococcus sanguinis BPA 2 6 19.3 19.2-19.4 15.6 15.3-16.3 7 ATCC10556 BPN 2 6 21.8 21.6-22.1 19 16.9-21.6 Positive 48 144 14.7 11.9 Total % Recovery 100% 100% *The 2 BTA 3D replicates had the same time to detection All bottles were positive Virtuo was on average 2.8 hours faster than BTA 3D 13

LRAP: Five day shelf life comparison Repeatability study Aliquots of LRAP was used for consecutive days within shelf life Rest of the LRAP was resealed and stored at RT on a rocker for next use Comparison analysis: day 3, 4 and 5 of LRAP Expiry Data collected for repeatability for LRAP without PAS were analyzed for TTD differences for both systems American Red Cross confirmed sterility testing was performed using the BacT/ALERT Detection System. Age of platelets did not impact results. A recent study with LRAP tested platelets on day 3 of shelf life. Preliminary results indicate similar results to previous testing. The age of platelets, throughout shelf life, did not impact results. Abstract on age of platelet data, was submitted to AABB, 2017 14

Summary and Conclusions Recovery of contaminants: Buffy coats and LRAP Both systems demonstrated equivalence in detecting low levels of contaminants TTD comparison: Buffy coats and LRAP Virtuo performance demonstrated an average of 2.3 hours faster TTD than BTA 3D Shelf Life comparison: LRAP Insignificant difference in TTD within 5 days of shelf life For optimal recovery and sensitivity, a paired Aerobic (BPA) and Anaerobic (BPN) bottles are recommended. VIRTUO is not yet commercially available for Platelets testing 15